1 withdrawn. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Withdrawn 1 |
Follow RDD1609: new trials by email Literature Review of RDD1609 trials Research Report on RDD1609
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| RDD1609 as a Treatment for Idiopathic Pruritus Ani RDD1609, Mebendazole 100 MG - Idiopathic Pruritus Ani | Phase 2 | Withdrawn | RDD Pharma Ltd | 2020-05-01 | 2022-11-03 |
RDD Pharma Ltd (1)
United Kingdom (1)
Jeanette Melrose, MD (1) · Nir Barak, MD (1)